⌘K

Login Start Free

Home/Filings/5/0001493152-21-003964

5//SEC Filing

Bolin Kevin 5

Accession 0001493152-21-003964

CIK 0001310527other

View on SEC.gov Company Profile

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 4:01 PM ET

Size

8.1 KB

Accession

0001493152-21-003964

Insider Transaction Report

Form 5

Period: 2020-12-31

QSAM Biosciences, Inc.QSAM

Director

Transactions

Award
COMMON STOCK
2020-12-17$0.22/sh+695,854$153,088→ 1,209,490 total
Conversion
COMMON STOCK
2020-09-30$0.22/sh+113,636$25,000→ 513,636 total

Holdings

Options to buy common stock
Exercise: $0.50From: 2016-02-25Exp: 2026-02-25→ COMMON STOCK (88,000 underlying)
88,000

Footnotes (2)

[F1]Shares acquired upon conversion of promissory note at a conversion price of $0.22 per share.
[F2]Shares acquired upon conversion of accured salary at a conversion price of $0.22 per share.

Documents

1 file

5
ownership.xmlPrimary

Issuer

QSAM Biosciences, Inc.

CIK 0001310527

Entity typeother

Related Parties

1

filerCIK 0001673956

Filing Metadata

Form type: 5
Filed: Feb 15, 7:00 PM ET
Accepted: Feb 16, 4:01 PM ET
Size: 8.1 KB

View on SEC.gov